Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

CLIENT NEWS

 

 

  • Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as “critical infrastructure” by the Federal Chancellery
    www.gba-group.com
  • AiCuris gets involved in the fight against Corona
    www.aicuris.com
  • APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19
    www.apeiron-biologics.com
  • France Biotech: A new Patient-Centered Endowment Fund launched by France Biotech: “HealthTech For Care”
    www.france-biotech.fr
  • BIO-Europe Spring® 2020 Stages Largest Fully Digital Life Science Partnering Event with Great Success
    www.ebdgroup.knect365.com
  • InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology
    www.inflarx.de
  • Newron AGM Result and Clinical and Business Update
    www.newron.com
  • Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD
    www.veronapharma.com
  • Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
    www.heidelberg-pharma.com
  • Heidelberg Pharma AG: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
    www.heidelberg-pharma.com